Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114154452> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W3114154452 endingPage "106" @default.
- W3114154452 startingPage "101" @default.
- W3114154452 abstract "Introduction: analysis of the effectiveness and safety of treatment of cognitive and affective narusheniy in the post-stroke period in patients with metabolic syndrome (MS) with the use of the drug Noofen®. The peculiarity of the work was clinical and neuroimaging comparison of MRI findings with cognitive impairment patients with and without MC.Research methods and materials. Conducted a survey of 50 patients after ischemic stroke with cognitive and affective disorders in age from 47 to 81 years (30 patients – main group: the standard treatment for 28 days was added Noofen®. 20 patients control group – standard treatment according to local protocols, without Noofen®). MRI scanner Toshiba Vantage Titan 1,5 T and workstation for post-processing images Vitrea determines the area of the corpus callosum (cm2).Research findings and discussion. It has been shown that in patients with MS after ischemic stroke often develop pathological fatigue, depression and anxiety disorders. After treatment, the indicators of the scales MMSE, MOCA, and tables Schulte significantly improved in the group of patients who received Noofen® and was determined a positive influence on pathological fatigue, anxiety. Comparison of the area of the corpus callosum in patients after stroke with and without MS showed a decrease in the size area in patients with MS. This probably reflects damage to the Association fibers, which are held in it and play an important role in providing the integrative activity of the brain. The consequence is found the correlation between the change of its area and the severity of cognitive impairment on the MOCA’ scale.Conclusions. Diagnosis of cognitive and emotional disorders in patients with MS in the early and late post-stroke periods can reduce pathological manifestations of fatigue, anxiety, depression, improve memory’yat, attention, speed of speech and is quicker to restore lost function. Measurement of the corpus callosum allow to predict disorders in cognitive and emotional spheres. The use of drug Noofen® in early and late post-stroke period contributes to the restoration of neurological deficit, cognitive functions and normalizes the emotional state of patients." @default.
- W3114154452 created "2021-01-05" @default.
- W3114154452 creator A5003960084 @default.
- W3114154452 creator A5039376324 @default.
- W3114154452 creator A5060801637 @default.
- W3114154452 creator A5082798434 @default.
- W3114154452 date "2016-03-22" @default.
- W3114154452 modified "2023-10-16" @default.
- W3114154452 title "Cognitive-affective disorders in post-stroke period in patients with metabolic syndrome" @default.
- W3114154452 cites W190916356 @default.
- W3114154452 cites W2293217045 @default.
- W3114154452 doi "https://doi.org/10.30841/2307-5112.1(63).2016.102293" @default.
- W3114154452 hasPublicationYear "2016" @default.
- W3114154452 type Work @default.
- W3114154452 sameAs 3114154452 @default.
- W3114154452 citedByCount "0" @default.
- W3114154452 crossrefType "journal-article" @default.
- W3114154452 hasAuthorship W3114154452A5003960084 @default.
- W3114154452 hasAuthorship W3114154452A5039376324 @default.
- W3114154452 hasAuthorship W3114154452A5060801637 @default.
- W3114154452 hasAuthorship W3114154452A5082798434 @default.
- W3114154452 hasBestOaLocation W31141544521 @default.
- W3114154452 hasConcept C118552586 @default.
- W3114154452 hasConcept C121332964 @default.
- W3114154452 hasConcept C126322002 @default.
- W3114154452 hasConcept C127413603 @default.
- W3114154452 hasConcept C15744967 @default.
- W3114154452 hasConcept C169900460 @default.
- W3114154452 hasConcept C24890656 @default.
- W3114154452 hasConcept C2780578515 @default.
- W3114154452 hasConcept C2780645631 @default.
- W3114154452 hasConcept C2781291010 @default.
- W3114154452 hasConcept C511355011 @default.
- W3114154452 hasConcept C70410870 @default.
- W3114154452 hasConcept C71924100 @default.
- W3114154452 hasConcept C78519656 @default.
- W3114154452 hasConceptScore W3114154452C118552586 @default.
- W3114154452 hasConceptScore W3114154452C121332964 @default.
- W3114154452 hasConceptScore W3114154452C126322002 @default.
- W3114154452 hasConceptScore W3114154452C127413603 @default.
- W3114154452 hasConceptScore W3114154452C15744967 @default.
- W3114154452 hasConceptScore W3114154452C169900460 @default.
- W3114154452 hasConceptScore W3114154452C24890656 @default.
- W3114154452 hasConceptScore W3114154452C2780578515 @default.
- W3114154452 hasConceptScore W3114154452C2780645631 @default.
- W3114154452 hasConceptScore W3114154452C2781291010 @default.
- W3114154452 hasConceptScore W3114154452C511355011 @default.
- W3114154452 hasConceptScore W3114154452C70410870 @default.
- W3114154452 hasConceptScore W3114154452C71924100 @default.
- W3114154452 hasConceptScore W3114154452C78519656 @default.
- W3114154452 hasIssue "1(63)" @default.
- W3114154452 hasLocation W31141544521 @default.
- W3114154452 hasOpenAccess W3114154452 @default.
- W3114154452 hasPrimaryLocation W31141544521 @default.
- W3114154452 hasRelatedWork W1997699231 @default.
- W3114154452 hasRelatedWork W2049567231 @default.
- W3114154452 hasRelatedWork W2075127398 @default.
- W3114154452 hasRelatedWork W2387117566 @default.
- W3114154452 hasRelatedWork W2423891131 @default.
- W3114154452 hasRelatedWork W2748952813 @default.
- W3114154452 hasRelatedWork W2899084033 @default.
- W3114154452 hasRelatedWork W3096578673 @default.
- W3114154452 hasRelatedWork W3157786390 @default.
- W3114154452 hasRelatedWork W2184766996 @default.
- W3114154452 hasVolume "0" @default.
- W3114154452 isParatext "false" @default.
- W3114154452 isRetracted "false" @default.
- W3114154452 magId "3114154452" @default.
- W3114154452 workType "article" @default.